Whalerock Point Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.25M | Buy |
14,740
+897
| +6% | +$487K | 1.4% | 17 |
|
|
2025
Q4 | $8.02M | Buy |
13,843
+105
| +0.8% | +$59.4K | 1.53% | 13 |
|
|
2025
Q3 | $6.66M | Sell |
13,738
-485
| -3% | -$226K | 1.35% | 18 |
|
|
2025
Q2 | $5.77M | Hold |
14,223
| – | – | 1.25% | 20 |
|
|
2025
Q1 | $7.08M | Buy |
14,223
+730
| +5% | +$395K | 1.68% | 15 |
|
|
2024
Q4 | $7.02M | Buy |
13,493
+304
| +2% | +$167K | 1.63% | 14 |
|
|
2024
Q3 | $8.16M | Buy |
13,189
+103
| +0.8% | +$61K | 1.94% | 11 |
|
|
2024
Q2 | $7.24M | Buy |
13,086
+208
| +2% | +$119K | 1.94% | 11 |
|
|
2024
Q1 | $7.48M | Buy |
12,878
+442
| +4% | +$248K | 2.04% | 11 |
|
|
2023
Q4 | $6.6M | Buy |
12,436
+67
| +0.5% | +$32.4K | 2.04% | 11 |
|
|
2023
Q3 | $6.26M | Buy |
12,369
+633
| +5% | +$337K | 2.17% | 11 |
|
|
2023
Q2 | $6.12M | Buy |
11,736
+418
| +4% | +$226K | 2.08% | 12 |
|
|
2023
Q1 | $6.52M | Buy |
11,318
+145
| +1% | +$81.7K | 2.42% | 7 |
|
|
2022
Q4 | $6.15M | Buy |
11,173
+107
| +1% | +$56.7K | 2.5% | 8 |
|
|
2022
Q3 | $5.61M | Buy |
11,066
+103
| +0.9% | +$57.6K | 2.47% | 8 |
|
|
2022
Q2 | $5.96M | Buy |
10,963
+10
| +0.1% | +$5.5K | 2.52% | 8 |
|
|
2022
Q1 | $6.47M | Buy |
10,953
+465
| +4% | +$267K | 2.29% | 11 |
|
|
2021
Q4 | $7M | Sell |
10,488
-65
| -0.6% | -$40.6K | 2.4% | 10 |
|
|
2021
Q3 | $6.03M | Buy |
10,553
+55
| +0.5% | +$30.2K | 2.34% | 10 |
|
|
2021
Q2 | $5.3M | Buy |
10,498
+35
| +0.3% | +$16.5K | 2.04% | 11 |
|
|
2021
Q1 | $4.78M | Buy |
10,463
+661
| +7% | +$315K | 2.1% | 12 |
|
|
2020
Q4 | $4.57M | Buy |
9,802
+6,121
| +166% | +$2.87M | 2.17% | 10 |
|
|
2020
Q3 | $3.68M | Sell |
3,681
-3,896
| -51% | -$1.61M | 2.03% | 12 |
|
|
2020
Q2 | $2.75M | Buy |
7,577
+674
| +10% | +$226K | 1.62% | 20 |
|
|
2020
Q1 | $1.96M | Buy |
6,903
+758
| +12% | +$239K | 1.4% | 22 |
|
|
2019
Q4 | $2M | Sell |
6,145
-110
| -2% | -$33.4K | 1.06% | 29 |
|
|
2019
Q3 | $1.82M | Buy |
6,255
+1,092
| +21% | +$313K | 0.98% | 30 |
|
|
2019
Q2 | $1.52M | Buy |
5,163
+36
| +0.7% | +$9.91K | 0.87% | 32 |
|
|
2019
Q1 | $1.4M | Buy |
5,127
+1,243
| +32% | +$309K | 0.92% | 35 |
|
|
2018
Q4 | $869K | Buy |
3,884
+824
| +27% | +$193K | 0.81% | 36 |
|
|
2018
Q3 | $747K | Buy |
3,060
+760
| +33% | +$175K | 0.54% | 49 |
|
|
2018
Q2 | $476K | Sell |
2,300
-828
| -26% | -$176K | 0.38% | 66 |
|
|
2018
Q1 | $646K | Buy |
3,128
+602
| +24% | +$126K | 0.21% | 85 |
|
|
2017
Q4 | $480K | Buy |
2,526
+10
| +0.4% | +$1.92K | 0.15% | 109 |
|
|
2017
Q3 | $476K | Sell |
2,516
-350
| -12% | -$63.4K | 0.17% | 91 |
|
|
2017
Q2 | $500K | Buy |
2,866
+66
| +2% | +$11.1K | 0.18% | 93 |
|
|
2017
Q1 | $431K | Sell |
2,800
-15
| -0.5% | -$2.29K | 0.16% | 93 |
|
|
2016
Q4 | $398K | Buy |
2,815
+500
| +22% | +$73.7K | 0.16% | 90 |
|
|
2016
Q3 | $368K | Buy |
+2,315
| New | +$357K | 0.15% | 96 |
|
|
2016
Q1 | $307K | Buy |
2,170
+75
| +4% | +$10.1K | 0.13% | 110 |
|
|
2015
Q4 | $297K | Buy |
+2,095
| New | +$279K | 0.13% | 116 |
|
Other funds holding TMO
VCM
Whalerock Point Partners's TMO Position: Q1 2026 in Review
Whalerock Point Partners increased its Thermo Fisher Scientific (TMO) stake by 6.5% in Q1 2026, buying an estimated $487K and bringing the position to 14,740 shares worth $7.25M. The position accounts for 1.4% of the portfolio, ranked #17.
Whalerock Point Partners first reported a position in TMO in Q4 2015 and has held it in 41 quarters since. The position peaked at $8.16M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Whalerock Point Partners held 14,740 shares of Thermo Fisher Scientific worth $7.25M as of Q1 2026.
- Whalerock Point Partners bought 897 Thermo Fisher Scientific shares in Q1 2026, an estimated $487K.
- Thermo Fisher Scientific made up 1.4% of Whalerock Point Partners's portfolio in Q1 2026, its #17 holding.
- Whalerock Point Partners first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 41 quarters since.
- Whalerock Point Partners's Thermo Fisher Scientific position peaked at $8.16M in Q3 2024.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Whalerock Point Partners's 13F filing for Q1 2026, filed 15 May 2026.